Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (2020), Packer M. | AcademicGPT, tlooto

SGLT2 inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes, regardless of the presence or absence of diabetes. (2020), NEW ENGLAND JOURNAL OF MEDICINE, Packer M. | AcademicGPT, tlooto for Academic and Research